EcoDrugPlus

Sem1 26s Proteasome Complex Subunit

Ensembl ID : ENSLOCG00000011004
Gene Symbol: SEM1
3 Cross references
155 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSLOCG00000002974
Gene Symbol: UGCG
3 Cross references
211 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSLOCG00000003652
Gene Symbol: WEE1
3 Cross references
226 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSLOCG00000011016
Gene Symbol: YES1
3 Cross references
269 Possible Orthologues:

Acetylcholinesterase (Cartwright Blood Group)

Ensembl ID : ENSLOCG00000014072
Gene Symbol: ACHE
3 Cross references
233 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSLOCG00000009939
Gene Symbol: ACVR2B
3 Cross references
257 Possible Orthologues:

Adenosine A1 Receptor

Ensembl ID : ENSLOCG00000010733
Gene Symbol: ADORA1
3 Cross references
273 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSLOCG00000007058
Gene Symbol: ADORA2A
3 Cross references
260 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSLOCG00000003553
Gene Symbol: ADORA2B
3 Cross references
200 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSLOCG00000001870
Gene Symbol: ADA
3 Cross references
216 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSLOCG00000012021
Gene Symbol: LOC102689714
2 Cross references
89 Possible Orthologues:

Adhesion Regulating Molecule 1

Ensembl ID : ENSLOCG00000005530
Gene Symbol: ADRM1
3 Cross references
255 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).